Alnylam Pharmaceuticals logo
Alnylam Pharmaceuticals
ALNY | NASDAQ
Chart Builder DCF Calculator
$159.73
-$5.31 (-3.22%)
At close: Nov 16, 2026, 4:00 PM ET
$160.00
+$0.27 (+0.17%)
Pre-market: Nov 17, 2026, 4:07 AM ET

Alnylam Pharmaceuticals Income Statement

Income statement explained
Fiscal Year
Period Ending
FY 2025
Dec 31, 2025
FY 2024
Dec 31, 2024
FY 2023
Dec 31, 2023
FY 2022
Dec 31, 2022
FY 2021
Dec 31, 2021
FY 2020
Dec 31, 2020
3.71B 2.25B 1.83B 1.04B 844.29M 492.85M
677.17M 323.37M 310.41M 168.82M 140.14M 78.05M
3.04B 1.92B 1.52B 868.6M 704.14M 414.8M
501.58M -176.89M -282.18M -785.07M -708.65M -828.44M
111.47M 121.99M 95.56M 24.81M 1.58M 11.81M
323.15M -377.38M -433.52M -1.13B -852.14M -855.6M
313.75M -278.16M -440.24M -1.13B -852.82M -858.28M
1.21B 975.53M 795.65M 770.66M 620.64M 588.42M
1.32B 1.13B 1B 883.02M 792.16M 654.82M
– – – – -2.05M –
2.54B 2.1B 1.8B 1.65B 1.41B 1.24B
252.63M 141.86M 121.22M 155.97M 143.02M 84.5M
– – – – – –
3.21B 2.43B 2.11B 1.82B 1.55B 1.32B
9.41M -99.22M 6.73M 4.16M 680K 2.68M
131M 127.65M 124.91M 121.69M 118.45M 114.99M
134.68M 127.65M 124.91M 121.69M 118.45M 114.99M
2.39 -2.18 -3.52 -9.30 -7.20 -7.46
2.33 -2.18 -3.52 -9.30 -7.20 -7.46
631.44M -178.85M -258.24M -926.56M -661.56M -696.67M
575.78M -235.52M -312.3M -971.03M -709.12M -771.1M
55.66M 56.67M 54.05M 44.47M 47.57M 74.44M

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.